Site-specific N-glycosylation of contactin-1 is involved in autoimmune targeting, and the recognition of contactin-1 with oligomannose-type N-glycans by autoantibodies from patients with CIDP leads to an enhanced disease state. The gene discussed is CNTN1; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.